| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94c85f2ecd392272b5a8b7e2c795fe9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ddec7200bed351109e6d65a710f9f4c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 |
| filingDate |
2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f88fa142fc99fca7923eccfd0d5380a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_481f556694aedcde9445b54526dcd264 |
| publicationDate |
2008-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008039941-A2 |
| titleOfInvention |
Scgb3a2 as a growth factor and anti-apoptotic agent |
| abstract |
The present disclosure is generally related to methods of using the secretory protein SCGB3A2 for promoting lung development and treating lung disease. Some embodiments are, for example, methods for treating and inhibiting the development of neonatal respiratory distress. Other embodiments are methods of promoting lung development in damaged or diseased lungs. Also disclosed are methods for inhibiting lung damage due to anti-cancer agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11690893-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11512121-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020113232-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018244735-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019143934-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10556938-B2 |
| priorityDate |
2006-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |